{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2016-02-04&max-ddpCreated=2016-02-04T21%3A03%3A54.767Z&answeringDeptId=17&max-ddpModified=2016-02-04T20%3A46%3A15.900Z&max-questionFirstAnswered.=2016-05-11T11%3A33%3A32.987Z", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?date=2016-02-04&max-ddpCreated=2016-02-04T21%3A03%3A54.767Z&answeringDeptId=17&max-ddpModified=2016-02-04T20%3A46%3A15.900Z&max-questionFirstAnswered.=2016-05-11T11%3A33%3A32.987Z", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2016-02-04&max-ddpCreated=2016-02-04T21%3A03%3A54.767Z&answeringDeptId=17&max-ddpModified=2016-02-04T20%3A46%3A15.900Z&_metadata=all&max-questionFirstAnswered.=2016-05-11T11%3A33%3A32.987Z", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2016-02-04&_page=0&max-ddpCreated=2016-02-04T21%3A03%3A54.767Z&answeringDeptId=17&max-ddpModified=2016-02-04T20%3A46%3A15.900Z&max-questionFirstAnswered.=2016-05-11T11%3A33%3A32.987Z", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2016-02-04&max-ddpCreated=2016-02-04T21%3A03%3A54.767Z&answeringDeptId=17&max-ddpModified=2016-02-04T20%3A46%3A15.900Z&max-questionFirstAnswered.=2016-05-11T11%3A33%3A32.987Z", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2016-02-04&max-ddpCreated=2016-02-04T21%3A03%3A54.767Z&answeringDeptId=17&max-ddpModified=2016-02-04T20%3A46%3A15.900Z&max-questionFirstAnswered.=2016-05-11T11%3A33%3A32.987Z", "items" : [{"_about" : "http://data.parliament.uk/resources/450608", "AnsweringBody" : [{"_value" : "Department of Health"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/450608/answer", "answerText" : {"_value" : "<p>The Human Fertilisation and Embryology Authority has advised that it requires, through its Code of Practice, that embryo donors will be recruited in a manner compliant with standard licence conditions. These conditions prevent conflict between the demands of research and the best interests of patients.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/127", "label" : {"_value" : "Biography information for Lord Prior of Brampton"}
        }
        , "answeringMemberPrinted" : {"_value" : "Lord Prior of Brampton"}
        , "dateOfAnswer" : {"_value" : "2016-02-12", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2016-02-12T08:28:20.207Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health"}
      , "answeringDeptSortName" : {"_value" : "Health"}
      , "date" : {"_value" : "2016-02-04", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Human Embryo Experiments"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask Her Majesty\u2019s Government, further to the Written Answer by Lord Prior of Brampton on 27 January (HL5039), what specific recommendations the Human Fertilisation and Embryology Authority has made in order to resolve any conflict between the demands of research and the best interests of patients, in particular regarding (1) a demand for sufficient numbers of human embryos at the single-celled zygote stage in order successfully to perform genome editing by means of CRISPR-Cas9, and (2) the usual practice of transferring embryos to the uterus after assessing their potential to develop further after either two to three days or five to six days.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/738", "label" : {"_value" : "Biography information for Lord Alton of Liverpool"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Lord Alton of Liverpool"}
      ], "uin" : "HL5909"}
    , {"_about" : "http://data.parliament.uk/resources/450609", "AnsweringBody" : [{"_value" : "Department of Health"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/450609/answer", "answerText" : {"_value" : "<p>The Human Fertilisation and Embryology Authority has advised that this research project will make use of donated embryos that were originally created for treatment purposes. An application was not made to create embryos for the purposes of this research project.<\/p><p> <\/p><p>The removal of \u2018surplus\u2019 from the title does not reflect a change in the way embryos will be donated to the research.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/127", "label" : {"_value" : "Biography information for Lord Prior of Brampton"}
        }
        , "answeringMemberPrinted" : {"_value" : "Lord Prior of Brampton"}
        , "dateOfAnswer" : {"_value" : "2016-02-11", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2016-02-11T15:07:15.83Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health"}
      , "answeringDeptSortName" : {"_value" : "Health"}
      , "date" : {"_value" : "2016-02-04", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Human Embryo Experiments"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask Her Majesty\u2019s Government, further to the Written Answer by Lord Prior of Brampton on 27 January (HL5039), whether the recently approved application by the Human Fertilisation and Embryology Authority to perform genome editing in human embryos by means of CRISPR-Cas9 will be performed on embryos specifically created for research or only on those considered to be surplus to infertility treatments; whether that research application included any application for the creation of embryos; and if not, why the person responsible requested that reference to surplus embryos should be removed from the research project title.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/738", "label" : {"_value" : "Biography information for Lord Alton of Liverpool"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Lord Alton of Liverpool"}
      ], "uin" : "HL5910"}
    , {"_about" : "http://data.parliament.uk/resources/450610", "AnsweringBody" : [{"_value" : "Department of Health"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/450610/answer", "answerText" : {"_value" : "<p>The Human Fertilisation and Embryology Authority (HFEA) has not received any such evidence. With regards the role of the HFEA in granting a research licence, its role is to ensure that any project fulfils one of the purposed set out below:<\/p><p> <\/p><p>- Increasing knowledge about serious disease or other serious conditions.<\/p><p>- Developing treatments for serious diseases or other serious medical conditions.<\/p><p>- Increasing knowledge about the causes of congenital diseases.<\/p><p>- Promoting the advances in the treatment of infertility.<\/p><p>- Increasing knowledge about the causes of miscarriages.<\/p><p>- Developing more efficient techniques of contraception.<\/p><p>- Developing methods for detecting gene, chromosome or mitochondrion abnormalities in embryos before implantation.<\/p><p>- Increasing knowledge about the development of embryos.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/127", "label" : {"_value" : "Biography information for Lord Prior of Brampton"}
        }
        , "answeringMemberPrinted" : {"_value" : "Lord Prior of Brampton"}
        , "dateOfAnswer" : {"_value" : "2016-02-12", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2016-02-12T13:23:38.967Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health"}
      , "answeringDeptSortName" : {"_value" : "Health"}
      , "date" : {"_value" : "2016-02-04", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Human Embryo Experiments"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask Her Majesty\u2019s Government, further to the Written Answer by Lord Prior of Brampton on 27 January (HL5039), what evidence the Human Fertilisation and Embryology Authority has received that a major cause of miscarriage is the failure of embryos to develop to the blastocyst stage; what records they hold regarding miscarriages occurring after human embryos that were known to be unable to develop further in vitro had been deliberately transferred to the uterus of a patient; and what sanctions are imposed on clinics in which such implantations take place.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/738", "label" : {"_value" : "Biography information for Lord Alton of Liverpool"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Lord Alton of Liverpool"}
      ], "uin" : "HL5911"}
    , {"_about" : "http://data.parliament.uk/resources/450624", "AnsweringBody" : [{"_value" : "Department of Health"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/450624/answer", "answerText" : {"_value" : "<p>The Department and Public Health England are currently undertaking a procurement exercise to secure vaccine to support the human papillomavirus (HPV) vaccination programme for girls and as this is a competitive tender, it would not be appropriate to pre-judge the outcome of that exercise. The procurement will take account of the costs and benefits of all vaccines offered to establish which provides best value for money for the National Health Service.<\/p><p> <\/p><p>The Department is considering the advice from the Joint Committee on Vaccination and Immunisation regarding HPV vaccination for men who have sex with men. Consideration will be given to the procurement of vaccine.<\/p><p><strong> <\/strong><\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/127", "label" : {"_value" : "Biography information for Lord Prior of Brampton"}
        }
        , "answeringMemberPrinted" : {"_value" : "Lord Prior of Brampton"}
        , "dateOfAnswer" : {"_value" : "2016-02-11", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2016-02-11T15:09:17.967Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health"}
      , "answeringDeptSortName" : {"_value" : "Health"}
      , "date" : {"_value" : "2016-02-04", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Human Papillomavirus: Vaccination"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask Her Majesty\u2019s Government whether the planned future HPV vaccine programme will also cover elimination of genital warts.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3573", "label" : {"_value" : "Biography information for Baroness Gould of Potternewton"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Baroness Gould of Potternewton"}
      ], "uin" : "HL5925"}
    , {"_about" : "http://data.parliament.uk/resources/450635", "AnsweringBody" : [{"_value" : "Department of Health"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/450635/answer", "answerText" : {"_value" : "<p>The Food Standards Agency (FSA) has identified the particular risk to children who frequently consume lead shot game. The FSA has advised since 2012 that those consuming high levels of such game should reduce their intake, and that this is especially important for vulnerable consumers such as children and pregnant women.<\/p><p> <\/p><p>This advice was widely reported in the media and on special interest group websites when it was published. The FSA reissued this advice last year. This advice is part of wider food safety advice on NHS Choices. The FSA is considering what further action is required to raise awareness of their advice, particularly with vulnerable groups such as parents and carers of young children.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/127", "label" : {"_value" : "Biography information for Lord Prior of Brampton"}
        }
        , "answeringMemberPrinted" : {"_value" : "Lord Prior of Brampton"}
        , "dateOfAnswer" : {"_value" : "2016-02-11", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2016-02-11T15:01:11.523Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health"}
      , "answeringDeptSortName" : {"_value" : "Health"}
      , "date" : {"_value" : "2016-02-04", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Game: Lead"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask Her Majesty\u2019s Government what recommendations they have made about what is a safe level of consumption of lead-shot game for children.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3736", "label" : {"_value" : "Biography information for Lord Krebs"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Lord Krebs"}
      ], "uin" : "HL5936"}
    ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 5, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}